GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » K Pharma Inc (TSE:4896) » Definitions » Total Tax Payable

K Pharma (TSE:4896) Total Tax Payable : 円1 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is K Pharma Total Tax Payable?

K Pharma's Total Tax Payable for the quarter that ended in Mar. 2024 was 円1 Mil.

K Pharma's quarterly Total Tax Payable declined from Sep. 2023 (円174 Mil) to Dec. 2023 (円70 Mil) and declined from Dec. 2023 (円70 Mil) to Mar. 2024 (円1 Mil).

K Pharma's annual Total Tax Payable increased from Dec. 2021 (円1 Mil) to Dec. 2022 (円2 Mil) and increased from Dec. 2022 (円2 Mil) to Dec. 2023 (円70 Mil).


K Pharma Total Tax Payable Historical Data

The historical data trend for K Pharma's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

K Pharma Total Tax Payable Chart

K Pharma Annual Data
Trend Dec21 Dec22 Dec23
Total Tax Payable
0.58 1.90 69.58

K Pharma Quarterly Data
Dec21 Dec22 Jun23 Sep23 Dec23 Mar24
Total Tax Payable Get a 7-Day Free Trial 1.90 201.62 173.98 69.58 0.58

K Pharma Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.


K Pharma Total Tax Payable Related Terms

Thank you for viewing the detailed overview of K Pharma's Total Tax Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


K Pharma (TSE:4896) Business Description

Traded in Other Exchanges
N/A
Address
7-7-7 Roppongi, Minato-ku, Tokyo, JPN, 106-0032
K Pharma Inc is a company involved in Research, development, manufacturing, sales and marketing of pharmaceutical products and regenerative medicine products. It is involved in studying of iPs cells in regnerative medecine to treat neurological conditions such as cerebral infarction and SCI.

K Pharma (TSE:4896) Headlines

No Headlines